{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:35:24Z","timestamp":1791110124391,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.brainresbull.2011.03.006","type":"journal-article","created":{"date-parts":[[2011,4,7]],"date-time":"2011-04-07T18:23:48Z","timestamp":1302200628000},"page":"194-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways"],"prefix":"10.1016","volume":"85","author":[{"given":"Jiang-Ping","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2011.03.006_bib0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/excr.2001.5152","article-title":"A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons","volume":"264","author":"Alvarez","year":"2001","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0025","article-title":"c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice","author":"Cancino","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"Chen","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00023210-200115050-00001","article-title":"The new generation of GABA enhancers. Potential in the treatment of epilepsy","volume":"15","author":"Czuczwar","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0045","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1523\/JNEUROSCI.3153-08.2008","article-title":"Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model","volume":"28","author":"Ding","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0050","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1523\/JNEUROSCI.23-27-09162.2003","article-title":"Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis","volume":"23","author":"Dou","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0169-328X(03)00294-8","article-title":"Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel","volume":"117","author":"Ekinci","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/neuro.02.002.2009","article-title":"Crosstalk between Cdk5 and GSK3beta: implications for Alzheimer's disease","volume":"2","author":"Engmann","year":"2009","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/iub.187","article-title":"GSK-3: a key player in neurodegeneration and memory","volume":"61","author":"Giese","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0070","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00702-004-0221-0","article-title":"Post-translational modifications of tau protein in Alzheimer's disease","volume":"112","author":"Gong","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0075","first-page":"359","article-title":"Biological markers in Alzheimer's disease","volume":"107","author":"Grundke-Iqbal","year":"2006","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0080","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1046\/j.1471-4159.1998.71062465.x","article-title":"New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry","volume":"71","author":"Hanger","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-1-18","article-title":"Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons","volume":"1","author":"Hoe","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0090","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer's disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/j.1460-2075.1993.tb05715.x","article-title":"Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation","volume":"12","author":"Hughes","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0100","first-page":"179","article-title":"Physiology and pathology of tau protein kinases in relation to Alzheimer's disease","volume":"121","author":"Imahori","year":"1997","journal-title":"J. Biochem."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/JAD-2006-9S325","article-title":"Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective","volume":"9","author":"Iqbal","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0115","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1471-4159.2009.05901.x","article-title":"Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD","volume":"108","author":"Kitazawa","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-2003-5207","article-title":"Cdk5: one of the links between senile plaques and neurofibrillary tangles?","volume":"5","author":"Lee","year":"2003","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0125","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1016\/j.febslet.2006.10.033","article-title":"PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners","volume":"580","author":"Liu","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0130","first-page":"309","article-title":"The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes","volume":"78","author":"Lovestone","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrd2111","article-title":"Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases","volume":"6","author":"Mazanetz","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0140","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1021\/bi100631f","article-title":"Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39","volume":"49","author":"Minegishi","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0145","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1074\/jbc.270.2.823","article-title":"Proline-directed and non-proline-directed phosphorylation of PHF-tau","volume":"270","author":"Morishima-Kawashima","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005072-199701000-00007","article-title":"Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain","volume":"56","author":"Pei","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2008.10.019","article-title":"The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1","volume":"235","author":"Plant","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0165","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0170","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo","volume":"35","author":"Sereno","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jnr.20051","article-title":"Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells","volume":"76","author":"Shelton","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00702-008-0021-z","article-title":"17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner","volume":"115","author":"Shi","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0190","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj3030701","article-title":"Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation","volume":"303","author":"Stambolic","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0195","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/bi035627j","article-title":"Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing","volume":"43","author":"Su","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(01)01864-X","article-title":"Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain","volume":"306","author":"Takashima","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0205","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4088\/JCP.09com05331","article-title":"Can lithium or valproate untie tangles in Alzheimer's disease?","volume":"70","author":"Tariot","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbapap.2003.11.019","article-title":"Cdk5, a therapeutic target for Alzheimer's disease?","volume":"1697","author":"Tsai","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0014-5793(02)02934-4","article-title":"A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains","volume":"523","author":"Tseng","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-4-18","article-title":"GSK-3beta phosphorylation of functionally distinct tau isoforms has differential, but mild effects","volume":"4","author":"Voss","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1326-5-46","article-title":"Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model","volume":"5","author":"Wang","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0230","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/417292a","article-title":"A common mechanism of action for three mood-stabilizing drugs","volume":"417","author":"Williams","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/rej.2009.0908","article-title":"Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway","volume":"13","author":"Yu","year":"2010","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0240","doi-asserted-by":"crossref","first-page":"31674","DOI":"10.1074\/jbc.M104309200","article-title":"The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth","volume":"276","author":"Yuan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2008.02.018","article-title":"Altered expression and distribution of zinc transporters in APP\/PS1 transgenic mouse brain","volume":"31","author":"Zhang","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2010.08.077","article-title":"An okadaic acid-induced model of tauopathy and cognitive deficiency","volume":"1359","author":"Zhang","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2010.04.074","article-title":"Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner","author":"Zhang","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2011.03.006_bib0260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.emboj.7600441","article-title":"A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons","volume":"24","author":"Zheng","year":"2005","journal-title":"EMBO J."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923011000943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923011000943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:12:16Z","timestamp":1759781536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923011000943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":52,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0361923011000943"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2011.03.006","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2011.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}